Skip to main content
. 2023 Sep 19;24(18):14292. doi: 10.3390/ijms241814292

Table 1.

Characteristics of the studies included in the systematic review and meta-analysis.

Study SR/MA Sample Size Age (Years) Sex (Female) % Study Type NAFLD Diagnosis Key Findings
Non-NAFLD NAFLD
Chiu L.S. et al. [8] MA 1972 384 52.1 ± 12 51.8 Cross-sectional Abdominal CT Framingham Heart Study Third Generation cohort
NAFLD patients had lower E/A, e′ and higher E, E/e′, LV mass.
BMI was a significant mediator between liver fat and LV diastolic dysfunction parameters.
Aksu E et al. [18] MA 43 31 32 ± 4 100 Case–control Liver ultrasonography Diastolic dysfunction indices were higher in the group of NAFLD compared to non-NAFLD (lateral E/e′ 5.8 ± 1.9 vs. 5.5 ± 2.0, p = 0.61, septal E/e′ 7.8 ± 2.2 vs. 6.5 ± 2.0, p = 0.01).
Moreover, the NAFLD group showed increased parameters of left ventricle hypertrophy, left atrial size, as well as increased inter- and intra-
atrial electromechanical delay.
Aparci et al. [19] MA 102 56 34.0 ± 6.7 34.2 Cross-sectional Liver ultrasonography NAFLD patients had lower E/A and significantly greater LA diameter. No information on E/e′ was provided.
VanWagner L.B. et al. [20] MA 2442 271 50.1 ± 3.6 46.5 Cross-sectional Abdominal CT NAFLD patients had higher LVMi, higher E/e’—findings of subclinical cardiac remodeling in systolic as well as diastolic function.
Bonapace S et al. [21] MA 18 32 64.1 ± 4.8 24 Cross-sectional Liver ultrasonography T2DM population
Diastolic dysfunction in NAFLD patients
Increased LV filling pressures
Cassidy S et al. [22] MA 19 19 55 ± 15 42 Case–control 1H-magnetic resonance spectroscopy of the liver Adults with NAFLD and T2DM demonstrate concentric remodeling with an elevated eccentricity ratio compared to controls. No data are provided on the ratio of E/e′, with similar LVMi across the two groups.
Chang W. et al. [23] MA 30 67 47.1 ± 8.9 33 Cross-sectional Liver ultrasonography T2DM population.
No significant difference among controls and mild NAFLD. LA strain values decreased in severe NAFLD group.
Chung G.E. et al. [24] MA 1990 1310 54 ± 10.2 36.8 Cross-sectional Liver ultrasonography Increased prevalence of LV diastolic dysfunction in NAFLD groups, as defined by E/A, E/e′, septal e′, LA, and LV dimensions.
Increased risk of diastolic dysfunction according to fibrosis in non-obese patient group following patient stratification according to BMI.
Fallo F. et al. [25] MA 38 48 49 ± 10 32 Case–control Liver ultrasonography Essential hypertensives patients
No data are provided regarding E/e’ ratio. Higher prevalence of diastolic dysfunction (62.5% vs. 21.1%, p < 0.001) in NAFLD compared to control subjects, as defined by E/A ratio < 1 and E-wave deceleration time > 220 ms.
Fotbolcu H et al. [26] MA 30 35 40.3 ± 6.2 41.5 Case–control Liver ultrasonography NAFLD patients had lower E/A and e’, increased DT, IVRT, and E/e’—increased LV filling pressures and impaired diastolic function.
Goland S. et al. [27] MA 25 38 44.8 ± 6.6 24.9 Case–control Liver biopsy NAFLD patients had altered LV geometry with pronounced thickening of IVS and PW, lower E/A, and increased DT. However, no significant differences in LV filling pressures (E/e’) were reported.
Ismaiel A. et al. [28] MA 37 38 42.1 ± 18.8 53.4 Cross-sectional Liver ultrasonography
SteatoTest
MAFLD patients had lower E/A compared to healthy controls and increased LV filling pressures as defined by E/e’.
Jung J.Y. et al. [29] MA 14,641 6171 39.7 ± 7.6 37.1 Cross-sectional Liver ultrasonography Impaired LV relaxation in NAFLD patients, with a correlation between NAFLD severity and degree of LV remodeling and diastolic dysfunction as measured with E/e’, LV mass, LVEDV, E/A, and tissue e’ velocities.
Khoshbaten M et al. [30] MA 30 30 40 ± 7 40 Case–control Liver ultrasonography NAFLD patients had increased LAVi compared to the controls.
Kim NH et al. [31] MA 1465 421 56.6 ± 7.3 62 Cross-sectional Computed tomography 4 groups: with and without NAFLD, with and without MetS.
No significant differences. The presence of NAFLD in subjects with MetS additively contributed to a subclinical deterioration in LV diastolic function.
Kocabay G et al. [32] MA 21 55 42.1 ± 7.3 43.1 Cross-sectional Liver biopsy LA geometry and functional properties assessed by speckle-tracking echo.
NAFLD patients had lower peak strain during atrial and ventricular systole.
LA strain during ventricular systole was significantly associated with E, Em, and LAVi values.
Atrial deformation parameters did not significantly differ among NAFLD groups according to liver disease severity.
Lai YH et al. [33] MA 1019 1142 48.1 ± 7.3 36.3 Retrospective cohort Liver ultrasonography NAFLD patients with increased fibrosis had significantly elevated E/e’, LA stiffness, decreased e’, and decreased LA strain values, independent of cardiovascular disease risk factors and obesity.
Lee H. et al. [34] MA 251 355 62.7 ± 5.1 75.5 Cross-sectional Liver ultrasonography T2DM population
LV diastolic dysfunction prevalence higher in NAFLD group with increased LV mass, LA dimensions, lower E/A ratio, and longer DT.
Lee M et al. [35] MA 48 83 60 44.3 Cross-sectional Elastography T2DM patients
NAFLD group had diastolic dysfunction with increased LV filling pressures (E/e’) and LAVi.
Higher degree of hepatic fibrosis independently associated with higher E/e’ ratio and decreased myocardial FDG uptake in PET
Lee YH et al. [36] MA 190 118 57.1 44.9 Cross-sectional Elastography NAFLD patients showed increased LV wall thickness, ventricular and atrial volumes, LV diastolic dysfunction as assessed by decreased e’ and increased LV filling pressures (E/e’), and atrial systolic dysfunction with reduced atrial longitudinal strain and increased atrial stiffness
Mahfouz RA et al. [37] MA 80 180 47.6 46.6 Case–control Elastography NAFLD patients had increased LA stiffness index values [as calculated with (E/e’)/LA global PALS ratio], interatrial septum thickness, LAVi and E/e’.
Higher AF prevalence in NAFLD group, possibly related to altered LA geometry
Mantovani, A. et al. [38] MA 64 158 67.4 29.6 Cross-sectional Liver ultrasonography T2DM outpatient population
NAFLD group had echocardiographic features of diastolic dysfunction; lower e’ and increased E/e’, LVEDP, and LAVi
Miller A et al. [39] MA 133 49 68.4 ± 12.9 58.6 Cross-sectional US/MRI/CT/biopsy/ICD-9/10 HFpEF patients
27% met NAFLD criteria with higher rates of NYHA III-IV HF symptoms and diastolic dysfunction grade ≥ 2, increased IVS thickness and LAVi.
Moise CG et al. [40] MA 80 79 31.5 ± 6.8 38.8 Case–control Liver ultrasonography Young (15–45) adult population
Hepatic steatosis was associated with lower e’ velocities, higher E/A, E/e’.
Concomitant DM did not affect diastolic dysfunction parameters.
Peng D et al. [41] MA 57 171 47.8 ± 12.1 32 Cross-sectional Liver ultrasonography or transient elastography Moderate-to-to severe steatosis patients had higher risks for left ventricle diastolic dysfunction and cardiac
remodeling with higher LVMi.
Saluja M et al. [42] MA 13 57 55.7 ± 10.4 45.1 Cross-sectional Liver ultrasonography T2DM population
NAFLD patient group had decreased e’ tissue velocities, increased E/e’ ratio, and elevated LVEDP.
Şerban A et al. [43] MA 70 73 57.5 ± 3.5 28.9 Case–control Liver ultrasonography T2DM population
NAFLD patient group had lower e’ tissue velocities, higher E/e’, more severe diastolic dysfunction
compared to controls.
Simon TG et al. [44] MA 51 14 48.4 ± 12.3 40.1 retrospective cohort Liver biopsy NAFLD patients had diastolic dysfunction echocardiographic parameters such as increased LAVi and LVMi, decreased e’ tissue velocities, E, E/A, and DT.
L. B. VanWagner et al. [45] MA 1668 159 49.9 ± 3.6 60.6 Prospective cohort Computed Tomography From CARDIA study
NAFLD patients had increased LAVi, LV mass and impaired LV relaxation with elevated LV filling pressures (higher E/e’).
Zamirian M et al. [46] MA 30 30 37.6 ± 4.7 48.3 Case–control Liver biopsy/
ultrasonography
NAFLD patients had altered LV geometry with increased diameters as well as diastolic dysfunction with lower e’ tissue velocities and higher E/e’.
Canada J McN et al. [47] SR - 36 54 (48–60) 67 Cross-sectional Biopsy confirmed NASH was compared to NAFL. Diastolic function was assessed according to liver fibrosis. E/e’ during exercise increased progressively with increasing fibrosis.
NASH was associated with impaired exercise capacity compared to NAFL.
Fudim M et al. [48] ΜA 842,616 27,919 74.5 ± 7.1 57 Cohort study International Classification of Diseases Patients with (versus without) baseline NAFLD had a significantly
higher risk of new-onset HF. Among HF subtypes, the association of NAFLD with downstream risk of HF was stronger for HFpEF.
Furuhashi M et al. [49] SR - 185 63 ± 14 43 Cross-sectional Fatty liver index Elevated fatty liver index is
independently associated with LV diastolic dysfunction in a general population without medication.
Makker J et al. [50] SR 94 64 - - Case–control Computed tomography Severe NAFLD compared to control was associated with a higher left ventricular mass after normalization for height2.7.
Petta S. et al. [51] SR - 147 48 ± 12 36 Cross-sectional Biopsy confirmed Left ventricular mass, relative wall thickness, and left atrial volume, as well as E/A
ratio and diastolic dysfunction were linked to severe liver fibrosis.
Sonaglioni A et al. [52] SR - 92 54 ± 11 50 Cross-sectional Liver stiffness measurement 12.0% of the NAFLD patients were found with normal diastolic filling pattern, 7.6%
showed a pseudonormal diastolic filling pattern, and
no patient was diagnosed with restrictive filling pattern.
Left ventricular filling pressures as expressed by
the average E/e’ ratio, were in the “gray zone” of 8 to 13
(average E/e’ ratio 10.0 ± 2.9).
Ybarra J et al. [53] SR - 151 38.4 ± 07 76 Cross-sectional Liver ultrasonography Increased prevalence of LVH according to ALT levels. Lower E/A ration according to ALT levels.
Yoshihisa A. Et al. [54] SR 492 69.8 ± 13.9 50.2 Prospective observational Non-alcoholic fatty liver disease fibrosis score Patients with HFpEF and NAFLD.
Higher NAFLD fibrosis score is associated with higher mortality, and higher BNP levels.

SR: systematic review, MA: meta-analysis, NAFLD: non-alcoholic fatty liver disease, LA: left atrial, LVMi: left ventricular mass index, T2DM: type 2 diabetes mellitus, BMI: body mass index, IVRT: isovolumic relaxation time, DT: deceleration time, IVS: interventricular septum, PW: posterior wall, LVEDV: left ventricular end-diastolic volume, MetS: metabolic syndrome, LAVi: left atrial volume index, HFpEF: heart failure with preserved ejection fraction, NYHA: New York Heart Association, LVEDP: left ventricular end-diastolic pressure, ALT: alanine transaminase, BNP: brain natriuretic peptide.